PLIVA FDA Approval ANDA 088467

ANDA 088467

PLIVA

FDA Drug Application

Application #088467

Application Sponsors

ANDA 088467PLIVA

Marketing Status

Prescription001

Application Products

001TABLET;ORAL25MG0HYDRALAZINE HYDROCHLORIDEHYDRALAZINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1984-05-01
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1985-03-15
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1985-03-15
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1985-05-22
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1986-02-21
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1986-07-22
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1986-06-04
LABELING; LabelingSUPPL8AP1988-03-25
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1990-04-04
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1994-05-11
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2000-07-07
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2001-06-08
LABELING; LabelingSUPPL14AP2001-10-11
LABELING; LabelingSUPPL29AP2010-11-01
LABELING; LabelingSUPPL40AP2013-01-28STANDARD
LABELING; LabelingSUPPL42AP2013-04-26STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL40Null15
SUPPL42Null15

TE Codes

001PrescriptionAA

CDER Filings

PLIVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 88467
            [companyName] => PLIVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDRALAZINE HYDROCHLORIDE","activeIngredients":"HYDRALAZINE HYDROCHLORIDE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDRALAZINE HYDROCHLORIDE","submission":"HYDRALAZINE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.